Hospital
SSM Health Care of Oklahoma, INC
SSM Health Care of Oklahoma, INC was paid $4.94M by Medicaid between Sep 2021 and Nov 2024, across 59 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoSSM HEALTH CARE OF OKLAHOMA, INC
MIDWEST CITY, OK 73110
MIDWEST CITY, OK 73110
33aNPI1700471497assigned 03/04/2021
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.94M
24GClaims56,011
24DCodes billed59
24AFirst – last monthSep 2021 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#32 of 75
Median peer was paid$3.66M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 4,383 | $319K | |
| 2022 | 16,482 | $1.44M | |
| 2023 | 22,276 | $1.98M | |
| 2024incomplete | 12,870 | $1.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 10,716 | 10,593 | $1.72M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 5,658 | 5,609 | $1.36M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9.0% | 3,165 | 3,118 | $443K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.3% | 1,016 | 1,008 | $360K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4.5% | 1,163 | 477 | $222K |
| J3490 | Unclassified drugs | 3.9% | 5,751 | 4,327 | $191K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 1,371 | 1,365 | $140K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 2,118 | 2,052 | $113K |
| 80053 | Comprehensive metabolic panel | 1.5% | 3,413 | 3,379 | $75K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 925 | 907 | $67K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,773 | 2,756 | $38K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,561 | 5,498 | $34K |
47 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 717 | $31K |
| 64493 | <1% | 50 | $19K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 201 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 979 | $16K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 53 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 263 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 152 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,538 | $8K |
| 81001 | <1% | 2,677 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 319 | $7K |
| 84484 | <1% | 406 | $6K | |
| 83735 | <1% | 752 | $4K | |
| 81025 | <1% | 532 | $4K | |
| 83690 | <1% | 563 | $3K | |
| 87400 | <1% | 210 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 61 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $2K |
| 80050 | General health panel | <1% | 64 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $2K |
| 80061 | Lipid panel | <1% | 210 | $2K |
| 82805 | <1% | 18 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $928.40 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 146 | $867.03 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $718.51 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 72 | $715.46 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 25 | $618.35 |
| 83880 | <1% | 13 | $419.04 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $367.50 |
| 84703 | <1% | 51 | $334.50 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $252.12 |
| 36415 | Collection of venous blood by venipuncture | <1% | 100 | $216.27 |
| 85610 | <1% | 56 | $194.82 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 486 | $156.16 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 387 | $145.79 |
| 84702 | <1% | 14 | $143.26 | |
| 87070 | <1% | 12 | $84.04 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 80 | $66.53 |
| 81003 | <1% | 33 | $62.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 834 | $1.59 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 50 | $1.48 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 13 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 51 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 45 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 18 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 12 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHODGES, JOE (CEO, SSM HEALTH CARE OF OKLAHOMA, I)
| Provider | Location | Paid |
|---|---|---|
| SSM Health Care of Oklahoma, INC | Midwest City, OK | $1.64M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.